CLYM - Latest News
Climb Bio, Inc. (CLYM), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $778.0M. Beta to the broader market is 0.03.
The article list below shows the most recent CLYM headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent CLYM Headlines
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
globenewswire.com - May 14, 2026
WELLESLEY HILLS, Mass. , May 14, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc.
Climb Bio to Present at Upcoming Investor Conferences
globenewswire.com - May 12, 2026
WELLESLEY HILLS, Mass. , May 12, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc.
Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com - May 7, 2026
Robust B-cell depletion observed with budoprutug subcutaneous formulation in healthy volunteers, supporting continued development CLYM116 modeling and
Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts
globenewswire.com - May 5, 2026
Robust B-cell depletion observed with budoprutug subcutaneous formulation in healthy volunteers, supporting continued development Budoprutug pMN, ITP,
Climb Bio, Inc. Announces $110.0 Million Private Placement
globenewswire.com - Apr 28, 2026
WELLESLEY HILLS, Mass. , April 28, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc.
How News Affects CLYM Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CLYM's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked CLYM news questions
- What is the latest CLYM news headline?
- The most recent CLYM headline (May 14, 2026) is "Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the CLYM news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What CLYM news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual CLYM options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.